A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates
Abstract Non-alcoholic steatohepatitis (NASH) is a progressive and severe liver disease, characterized by lipid accumulation, inflammation, and downstream fibrosis. Despite its increasing prevalence, there is no approved treatment yet available for patients. This has been at least partially due to t...
Enregistré dans:
Auteurs principaux: | Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, Eva Thoma |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f68ec732dd9c4e5cbe369ca6c1215b3e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Statins in Non-alcoholic Steatohepatitis
par: Jose D. Torres-Peña, et autres
Publié: (2021) -
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
par: Chengyuan Liang, et autres
Publié: (2021) -
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
par: Philippe Garteiser, et autres
Publié: (2021) -
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
par: Justine Gillard, et autres
Publié: (2022) -
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
par: Joost Willebrords, et autres
Publié: (2017)